Open Actively Recruiting

Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

About

Brief Summary

This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.

Primary Purpose
Screening
Study Type
Interventional
Phase
N/A

Eligibility

Gender
All
Healthy Volunteers
Yes
Minimum Age
40 Years
Maximum Age
80 Years

Inclusion Criteria:

  • Age:
    • Breast screening > 40
    • Lung screening 50-80
  • Male (M) or Female (F)
  • Current, former, or never smokers
  • Close family or friend with smoking history (in or out of state)

Exclusion Criteria:

  • Age:
    • Breast screening < 40
    • Lung screening < 50 or > 80
  • Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded
  • Persons with an active cancer

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
22-000947
Category
Breast Cancer
Lung Cancer
Contact
Amelia Ferrer
Location
  • UCLA Santa Monica
  • UCLA Westwood
For Providers
NCT No.
NCT05978128
For detailed technical eligibility, visit ClinicalTrials.gov.